No Data
Truist Financial Maintains Lantheus(LNTH.US) With Buy Rating
JonesTrading Maintains Lantheus(LNTH.US) With Buy Rating, Maintains Target Price $128
Unusual Options Activity: CVS, DKNG and Others Attract Market Bets, CVS V/OI Ratio Reaches 137.5
Lantheus Holdings Acquires Global Rights to Life Molecular Imaging's RM2
Lantheus Expands Cancer Pipeline With $35M Acquisition of RM2 Rights
Express News | Lantheus Holdings Inc - to Begin Phase 1/2a Study With (177)Lu-Dota-Rm2 in 2025